The role of mRNA decay in p53-induced gene expression

RNA

Volumn 17, Issue 12, 2011, Pages 2222-2234

  Melanson, Brian D ^a,b   Bose, Reetesh ^a,b   Hamill, Jeff D ^a   Marcellus, Kristen A ^a   Pan, Elysia F ^a   McKay, Bruce C ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cell cycle arrest; Gene expression; Microarray; mRNA decay; p53 response

Indexed keywords

ALANINE; CYTOSINE; GLYCINE; GROWTH DIFFERENTIATION FACTOR 15; MESSENGER RNA; OLIGONUCLEOTIDE; PROTEIN; PROTEIN CRYAB; PROTEIN DDB2; PROTEIN P53; UNCLASSIFIED DRUG; URIDINE;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MESSENGER RNA DECAY; MICROARRAY ANALYSIS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; TEMPERATURE SENSITIVITY;

3' UNTRANSLATED REGIONS; ANIMALS; BASE COMPOSITION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; MICE; MUTATION; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 81755161590     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.030122.111     Document Type: Article

References (61)

1. Bakheet T, Williams BR, Khabar KS. 2006. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34: D111-D114.
2. Barreau C, Paillard L, Osborne HB. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33: 7138-7150. (Pubitemid 43125082)
3. Batchelor E, Loewer A, Lahav G. 2009. The ups and downs of p53: Understanding protein dynamics in single cells. Nat Rev Cancer 9: 371-377.
4. Bates S, Hickman ES, Vousden KH. 1999. Reversal of p53-induced cell-cycle arrest. Mol Carcinog 24: 7-14. (Pubitemid 29070238)
5. Beißbarth T, Speed TP. 2004. GOstat: Find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20: 1464-1465. (Pubitemid 38931420)
6. WAF1/CIP1 expression. Biochem Biophys Res Commun 227: 564-569.
7. Caelles C, Helmberg A, Karin M. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223. (Pubitemid 24236778)
8. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825. (Pubitemid 23346378)
9. 1 arrest and apoptosis. Cancer Res 54: 1169-1174.
10. Elkon R, Zlotorynski E, Zeller KI, Agami R. 2010. Major role for mRNA stability in shaping the kinetics of gene induction. BMC Genomics 11: 259. doi: 10.1186/1471-2164-11-259.
11. Friedel CC, Dölken L, Ruzsics Z, Koszinowski UH, Zimmer R. 2009. Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res 37: e115. doi: 10.1093/nar/gkp542.
12. Gannon JV, Lane DP. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349: 802-806. (Pubitemid 21912170)
13. Geske FJ, Lieberman R, Strange R, Gerschenson LE. 2001. Early stages of p53-induced apoptosis are reversible. Cell Death Differ 8: 182-191. (Pubitemid 32201365)
14. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, et al. 2006. Oscillations and variability in the p53 system. Mol Syst Biol 2: 2006.0033. doi: 10.1038/msb4100068.
15. Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol Cell Biol 18: 1400-1407.
16. Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, Banfi S, Gennarino VA, Horner DS, Pavesi G, Picardi E, et al. 2010. UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 38: D75-D80.
17. Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, Bohjanen PR. 2007. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J Cell Biochem 100: 1477-1492. (Pubitemid 46515580)
18. Hogg JR. 2011. This message was inspected by Upf1: 3′UTR length sensing in mRNA quality control. Cell Cycle 10: 372-373.
19. Hogg JR, Goff SP. 2010. Upf1 senses 3′UTR length to potentiate mRNA decay. Cell 143: 379-389.
20. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253: 49-53. (Pubitemid 21917115)
21. Honda R, Tanaka H, Yasuda H. 1997. OncoproteinMDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27. (Pubitemid 28037193)
22. Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
23. Kannan K, Amariglio N, Rechavi G, Givol D. 2000. Profile of gene expression regulated by induced p53: connection to the TGF-β family. FEBS Lett 470: 77-82. (Pubitemid 30155627)
24. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D. 2001. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20: 2225-2234. (Pubitemid 32531280)
25. Lahav G. 2004. The strength of indecisiveness: Oscillatory behavior for better cell fate determination. Sci STKE 2004: pe55. doi: 10.1126/stke. 2642004pe55.
26. Lahav G. 2008. Oscillations by the p53-Mdm2 feedback loop. Adv Exp Med Biol 641: 28-38.
27. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, Averett LM, Zhao H, Davis RE, Sathyamoorthy M, et al. 2001. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol 2: research0041-research0041.11.
28. Lee JE, Lee JY, Wilusz J, Tian B, Wilusz CJ. 2010. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS ONE 5: e11201. doi: 10.1371/journal.pone. 0011201.
29. Ljungman M, Lane DP. 2004. Transcription-guarding the genome by sensing DNA damage. Nat Rev Cancer 4: 727-737. (Pubitemid 39215071)
30. Mata J, Marguerat S, Bähler J. 2005. Post-transcriptional control of gene expression: a genome-wide perspective. Trends Biochem Sci 30: 506-514. (Pubitemid 41206506)
31. McKay BC, Ljungman M, Rainbow AJ. 1999. Potential roles for p53 in nucleotide excision repair. Carcinogenesis 20: 1389-1396. (Pubitemid 29385420)
32. McKay BC, Chen F, Perumalswami CR, Zhang F, Ljungman M. 2000. The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis. Mol Biol Cell 11: 2543-2551. (Pubitemid 30645025)
33. McKay BC, Stubbert LJ, Fowler CC, Smith JM, Cardamore RA, Spronck JC. 2004. Regulation of ultraviolet light-induced gene expression by gene size. Proc Natl Acad Sci 101: 6582-6586. (Pubitemid 38586017)
34. Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC. 2004. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet 36: 1073-1078. (Pubitemid 41184468)
35. Merchant AK, Loney TL, Maybaum J. 1996. Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells. Oncogene 13: 2631-2637. (Pubitemid 27046640)
36. Michalovitz D, Halevy O, Oren M. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680.
37. Mignone F, Gissi C, Liuni S, Pesole G. 2002. Untranslated regions of mRNAs. Genome Biol 3: reviews0004-reviews0004.10.
38. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
39. Montes de Oca Luna R, Wagner DS, Lozano G. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
40. Muhlrad D, Parker R. 1999. Aberrant mRNAs with extended 3′ UTRs are substrates for rapid degradation by mRNA surveillance. RNA 5: 1299-1307. (Pubitemid 29489812)
41. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Mühlemann O. 2010. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67: 677-700.
42. Proctor CJ, Gray DA. 2008. Explaining oscillations and variability in the p53-Mdm2 system. BMC Syst Biol 2: 75. doi: 10.1186/1752-0509-2-75.
43. Raghavan A, Bohjanen PR. 2004. Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression. Brief Funct Genomic Proteomic 3: 112-124.
44. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, St. Louis-Vlasova IA, Bohjanen PR. 2010. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30: 3970-3980.
45. Rebbapragada I, Lykke-Andersen J. 2009. Execution of nonsense-mediated mRNA decay: what defines a substrate? Curr Opin Cell Biol 21: 394-402.
46. Rehwinkel J, Letunic I, Raes J, Bork P, Izaurralde E. 2005. Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets. RNA 11: 1530-1544. (Pubitemid 41396923)
47. Rehwinkel J, Raes J, Izaurralde E. 2006. Nonsense-mediated mRNA decay: target genes and functional diversification of effectors. Trends Biochem Sci 31: 639-646. (Pubitemid 44635264)
48. Riley T, Sontag E, Chen P, Levine A. 2008. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412. (Pubitemid 351574202)
49. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. 1990. p53 mutations in colorectal cancer. Proc Natl Acad Sci 87: 7555-7559. (Pubitemid 20341755)
50. Sharova LV, Sharov AA, Nedorezov T, Piao Y, Shaik N, Ko MS. 2009. Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res 16: 45-58.
51. Smith JM, Stubbert LJ, Hamill JD, McKay BC. 2007. The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specific. Neoplasia 9: 1057-1065. (Pubitemid 350255354)
52. Stubbert LJ, Hamill JD, Spronck JC, Smith JM, Becerril C, McKay BC. 2007. DDB2-independent role for p53 in the recovery from ultraviolet light-induced replication arrest. Cell Cycle 6: 1730-1740. (Pubitemid 47327926)
53. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, SternJohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, et al. 2008. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29: 263-270. (Pubitemid 351172819)
54. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M. 2000. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20: 760-769. (Pubitemid 30044212)
55. Wright GW, Simon RM. 2003. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455. (Pubitemid 38016644)
56. Wu X, Bayle JH, Olson D, Levine AJ. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132. (Pubitemid 23207405)
57. Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, Magnasco M, Darnell JE Jr. 2003. Decay rates of human mRNAs: Correlation with functional characteristics and sequence attributes. Genome Res 13: 1863-1872. (Pubitemid 36987192)
58. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347. (Pubitemid 21912356)
59. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. 1999. Identification and classification of p53-regulated genes. Proc Natl Acad Sci 96: 14517-14522. (Pubitemid 30000682)
60. Zhang XP, Liu F, Cheng Z, Wang W. 2009. Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci 106: 12245-12250.
61. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ. 2000. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993. (Pubitemid 30253006)